Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 12:12:685041.
doi: 10.3389/fpsyt.2021.685041. eCollection 2021.

The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Is Associated With Female Obsessive-Compulsive Disorder: An Updated Meta-Analysis of 2765 Obsessive-Compulsive Disorder Cases and 5558 Controls

Yanan Shang  1 , Na Wang  2 , En Zhang  3 , Qian Liu  1 , Hengfen Li  1 , Xiaofeng Zhao  1
Affiliations

The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Is Associated With Female Obsessive-Compulsive Disorder: An Updated Meta-Analysis of 2765 Obsessive-Compulsive Disorder Cases and 5558 Controls

Yanan Shang et al. Front Psychiatry. .

Abstract

Objective: Accumulated evidence has implicated that brain-derived neurotrophic factor (BDNF) gene polymorphisms play a role in the etiology of obsessive-compulsive disorder (OCD). A single nucleotide polymorphism in the coding exon of the BDNF gene at position 66, Val66Met (rs6265), is found to be associated with OCD in different populations, but results linking Val66Met with OCD have been inconsistent and inconclusive. In our study we performed a meta-analysis to further examine whether rs6265 genetic variants are involved in the etiology of OCD. Methods: By searching databases, relevant case-control studies were retrieved; using established inclusion criteria, we selected eligible studies for analysis. Results: Thirteen studies were identified that examined the association between the rs6265 polymorphism and OCD. After statistical analyses, no significant association was found between the rs6265 polymorphism and OCD (OR = 1.07, 95% CI = 1.00-1.15, P = 0.06 for genotype; OR = 1.06, 95% CI = 0.98-1.15, P = 0.15 for allele). However, in gender-specific analysis, female Val carriers might be a risk factor for OCD (OR = 1.36, 95% CI = 1.03-1.80, P = 0.03 for genotype; OR = 1.15, 95% CI = 1.01-1.32, P = 0.04 for allele). Conclusion: Our updated meta-analysis suggests that female carriers of the Val66Met BDNF polymorphism might be more suspectable to develop OCD.

Keywords: Val66Met polymorphism; brain-derived neurotrophic factor (BDNF) gene; female; meta-analysis; obsessive-compulsive disorder (OCD).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The process of independent studies for inclusion in this meta-analysis.
Figure 2
Figure 2
Results of the random-effects meta-analysis for the BDNF Val66Met allele (Val vs. Met) in OCD and control groups.
Figure 3
Figure 3
Results of the random-effects meta-analysis for the BDNF Val66Met genotype (Val/Val+Val/Met vs. Met/Met) in OCD and control groups.
Figure 4
Figure 4
Results of the random-effects meta-analysis for the BDNF Val66Met Val carriers in male OCD and control groups, respectively.
Figure 5
Figure 5
Results of the random-effects meta-analysis for the BDNF Val66Met Val carriers in female OCD and control groups.
Figure 6
Figure 6
Results of sensitivity analysis.
See this image and copyright information in PMC

References

    1. van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet. (2005) 8:450–8. 10.1375/twin.8.5.450 - DOI - PubMed
    1. Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. (2013) 14:7–23. 10.1038/nrn3379 - DOI - PubMed
    1. Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci. (2015) 11:1164–78. 10.5114/aoms.2015.56342 - DOI - PMC - PubMed
    1. Guo HR, Huang BL, Wang YL, Zhang YY, Ma QG, Lv PP, et al. . Effect of escitalopram on serum GDNF and BDNF levels and 5-HT level of brain tissue of obsessive-compulsive disorder rats. Cell Mol Neurobiol. (2020) 40:991–7. 10.1007/s10571-020-00788-4 - DOI - PMC - PubMed
    1. Maina G, Rosso G, Zanardini R, Bogetto F, Gennarelli M, Bocchio-Chiavetto L. Serum levels of brain-derived neurotrophic factor in drug-na?ve obsessive-compulsive patients: a case -control study. J Affect Disord. (2010) 122:174–8. 10.1016/j.jad.2009.07.009 - DOI - PubMed

Publication types

LinkOut - more resources